For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
-
Narrated by:
-
By:
About this listen
Featuring perspectives from Ms Ilene Galinsky, Dr Michael J Mauro, Dr Neil P Shah and Dr Sara M Tinsley-Vance, including the following topics:
- Introduction: Chronic Myeloid Leukemia (CML) as a Model for Targeted Treatment (0:00)
- Biology of CML; Role of First- and Second-Generation Tyrosine Kinase Inhibitors (TKIs) as Initial Treatment for Chronic-Phase (CP) CML (12:37)
- Role of Asciminib for Newly Diagnosed CP-CML (47:46)
- Feasibility of TKI Discontinuation for Patients with Sustained Response to Treatment (1:14:06)
- Management of CP-CML After Failure of Initial Therapy (1:23:04)
NCPD information and select publications
No reviews yet